Cargando…
Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891450/ https://www.ncbi.nlm.nih.gov/pubmed/36742184 http://dx.doi.org/10.1097/BS9.0000000000000137 |
| _version_ | 1784881138792136704 |
|---|---|
| author | Li, Qiang Yang, Zhihuan Fang, Kuo Wei, Shuning Sun, Jiali Liu, Wei Chen, Xiaojuan Huang, Wenyang Zhang, Guangji Shi, Yin Liu, Yuntao Gong, Xiaoyuan Liu, Fang Zhou, Xueli Wang, Jianxiang Wang, Ying |
| author_facet | Li, Qiang Yang, Zhihuan Fang, Kuo Wei, Shuning Sun, Jiali Liu, Wei Chen, Xiaojuan Huang, Wenyang Zhang, Guangji Shi, Yin Liu, Yuntao Gong, Xiaoyuan Liu, Fang Zhou, Xueli Wang, Jianxiang Wang, Ying |
| author_sort | Li, Qiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9891450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98914502023-02-02 Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy Li, Qiang Yang, Zhihuan Fang, Kuo Wei, Shuning Sun, Jiali Liu, Wei Chen, Xiaojuan Huang, Wenyang Zhang, Guangji Shi, Yin Liu, Yuntao Gong, Xiaoyuan Liu, Fang Zhou, Xueli Wang, Jianxiang Wang, Ying Blood Sci Case Report Lippincott Williams & Wilkins 2022-10-27 /pmc/articles/PMC9891450/ /pubmed/36742184 http://dx.doi.org/10.1097/BS9.0000000000000137 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Medical Association (CMA) and Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (IHCAMS). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Case Report Li, Qiang Yang, Zhihuan Fang, Kuo Wei, Shuning Sun, Jiali Liu, Wei Chen, Xiaojuan Huang, Wenyang Zhang, Guangji Shi, Yin Liu, Yuntao Gong, Xiaoyuan Liu, Fang Zhou, Xueli Wang, Jianxiang Wang, Ying Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_full | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_fullStr | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_full_unstemmed | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_short | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_sort | reduced abo blood group antibody titers in patients after cd19 car-t cell therapy |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891450/ https://www.ncbi.nlm.nih.gov/pubmed/36742184 http://dx.doi.org/10.1097/BS9.0000000000000137 |
| work_keys_str_mv | AT liqiang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT yangzhihuan reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT fangkuo reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT weishuning reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT sunjiali reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT liuwei reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT chenxiaojuan reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT huangwenyang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT zhangguangji reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT shiyin reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT liuyuntao reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT gongxiaoyuan reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT liufang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT zhouxueli reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT wangjianxiang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT wangying reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy |